breast cancer - adjuvant | breast cancer - HR positive | ||
breast cancer - adjuvant | la/mBC - HR-positive - 1st line (L1) | la/mBC - HR-positive - 2nd line (L2) | |
abemaciclib based treatment | |||
abemaciclib plus aromatase inhibitor | MONARCH 3 | ||
abemaciclib plus endocrine therapy | |||
abemaciclib plus fulvestrant | MONARCH 2 |